Elimination of deaths from postpartum haemorrhage

While international developmental partners tend to have similar objectives regarding PPH priorities, efforts are often misaligned because of a lack of cohesive coordination at the global and country levels, as well as a lack of end-to-end thinking as it pertains to product development, introduction, and impact assessment.

Academic researchers and innovators in industry often do not know what type of evidence to generate and how to connect evidence to policy decision-making, leading to a lot of research waste, and a painfully slow process of translating research ideas to clinical impact at the patient level.

Likewise, target product profiles (TPP) have not generally been described prior to R & D of PPH interventions, and the concept of target policy profiles (TPop) (to identify key research questions to support policy changes at the point of evidence generation and dissemination) is relatively new to those who make research funding decisions. In short, there is no clarity on what is in the pipeline regarding PPH products or interventions, or on what an ideal future PPH products or policy requirements should look like. 

In recognition of the need for global action to improve the quality of PPH care, WHO and HRP convened a PPH Summit from 7 to 10 March 2023 to bring together all relevant stakeholders – ministries of health, academic institutions, non-governmental organizations, healthcare professional associations, industry and private sector, UN agencies and international donors – to review and prioritize the most urgent PPH priorities to fast-track progress towards SDG 3.1 target in terms of research, guidelines, advocacy and country-level implementation.